Fig. 2From: Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical studyPrimary outcomes. A Probability for Viral Load Negativization. B Change in Log10 Viral Load. C Change in anti-SARS-CoV-2 S1 IgG antibodies. D Change in anti-SARS-CoV-2 S1 IgA antibodies. OR: Odds ratio; CI: Confidence intervalBack to article page